Pharmacoeconomic Evaluation, Cost Minimization Analysis of Anti-Diabetic Therapy in Gujarat

Journal Title: International Journal of Medical Research & Health Sciences - Year 2016, Vol 5, Issue 3

Abstract

Economic burden of DM was approximated $ 132 billion in 2002. 55 patients with DM were recruited. Their clinical information was analyzed for most commonly and most costly prescribed drug molecule. Three brands of both drugs were selected and laboratory analysis was done for all the selected brands to compare the bioequivalence. For the rest of drugs prescribed, the prices were compared using published resources. Metformin 500 mg was the most commonly prescribed drug. Sitagliptin 50 mg was the costliest drug prescribed. Glycomet, Glyciphage and Forson were the brands of Metformin, Januvia and Zeta were the brands of Sitagliptin, selected for lab analysis. The drug content for metformin in Glycomet (100%), Glyciphage (99.24%) and Forson (98.95%) for Sitagliptin, Januvia (100%) and Zeta (102.43%) was nearly same. The price variation of Metformin was found to be 94.83% and that of Sitagliptin was found to be 174.5%. Since it is evident that same drug molecule varying in costs has same drug strength content they would produce similar clinical outcomes. This concludes that cheaper drugs can be prescribed to patients reducing the health-economic burden on diabetic patients.

Authors and Affiliations

Shah Jainam V.

Keywords

Related Articles

Surgical therapeutic management of perforated peptic ulcer

Perforated peptic ulcer is an emergency should be readily corrected by surgical approach to reduce potential damage and the risk of mortality associated with the extension frame. The option of handling most commonly used...

RPOB gene mutation in rifampicin resistant MRSA from foot infections of patients having diabetes mellitus

Staphylococcus aureus is an opportunistic bacterial pathogen associated with asymptomatic colonization of the skin and mucosal surfaces of normal humans. Staphylococcus aureus isolates are often multidrug resistant. Rifa...

Patient-Centered Care; Physicians’ View of Obstacles against and Ideas for Implementation

To implement proper family medicine practice and to get the best of it, the concept of patient-centered care (PCC) has to be put into use. Studies have found that one of the most important advantages of PCC is the increa...

The effectiveness of E- learning in learning: A review of the literature

Entry to the information age and effective life in information-oriented society requires an understanding of its characteristics. One of the social institutions that will undergo extensive changes at this age is general...

A seroprevalence evaluation study of Hepatitis B virus, Hepatitis C virus and Herpes Simplex Virus - 2 among a special study group

Viral STI are silent diseases. Most of them are symptomless, but have the potential to be transmitted to fetus and other sexual partners. Female sex workers, men who have sex with men are at high risk of getting STIs an...

Download PDF file
  • EP ID EP247560
  • DOI -
  • Views 142
  • Downloads 0

How To Cite

Shah Jainam V. (2016). Pharmacoeconomic Evaluation, Cost Minimization Analysis of Anti-Diabetic Therapy in Gujarat. International Journal of Medical Research & Health Sciences, 5(3), 34-43. https://europub.co.uk/articles/-A-247560